Deutsche is looking to drop the "bad bank" moniker with big moves on Monday.
Intra-Cellular Therapies and Acadia Pharmaceuticals are worth investors' attention.
The Federal Aviation Administration has declined to set a timeline on when it will lift its order prohibiting the troubled aircraft from flying.
The G-20 Summit in Japan could hold more intrigue than just the planned meeting between President Trump and Xi.
A number of vocal analysts and investors are calling for caution on those eager to buy the semiconductor stock amidst its Wednesday morning leap.
Micron is motivating more positive outlook on the semiconductor sector's road ahead.
Despite the financial positivity, many analysts warn the deal could have hiccups ahead.
PFE was ready to pay $160 billion until U.S. regulators blocked the deal.
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
A bit of context to simmer on following the big deal between Caesars and Eldorado.